Clinical Trial Update: Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) [Phase 2]

View source ↗

Summary

Phase 2 trial of a glucocorticoid receptor antagonist for Borderline Personality Disorder was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Snippet

Sponsor: Indiana University | Conditions: Borderline Personality Disorder | Phase 2 | Status: TERMINATED | Results posted: 2019-02-26